Current epidemiology of Staphylococcus aureus with decreased susceptibility to glycopeptides (vancomycin and teicoplanin) in France
Author(s): Allouch PY, Astagneau P, Aubry Damon H, Bismuth R, Brun Buisson C, Buu Hoi A, Carlet J, Chesneau O, Chaperon J, Courvalin P, Desenclos JC, Drucker J, Drugeon H, El Solh N, Etienne J, Fabry J, Gutmann L, Jarlier V, Joly C, Kac G, Leclercq R, Legrand P, Mainardi JL, Meunier O, Parneix P, Pierre V, Podglajen I, Ploy MC, Rauss A, Reverdy ME, Savey A, Soussy CJ, Struelens M, Tran B
Publishing year: 2000
In relation to
Our latest news
news
Arboviral Diseases in 2026: Mosquito-Borne Diseases Continue to Spread This...
news
Andes Hantavirus: Implementation of epidemiological investigations and...
news